The Secretion of IL-22 from Mucosal NKp44+ NK Cells Is Associated with Microbial Translocation and Virus Infection in SIV/SHIV-Infected Chinese Macaques

The Secretion of IL-22 from Mucosal NKp44+ NK Cells Is Associated with Microbial Translocation and Virus Infection in SIV/SHIV-Infected Chinese Macaques

Microbial translocation (MT) causes systemic immune activation in chronic human immunodeficiency virus (HIV) infection. The role of a novel subtype of innate lymphoid cells, the NKp44+ NK cells, in HIV/simian immunodeficiency virus- (SIV-) induced MT remains unknown. In this study, 12 simian-human i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Wang, Fangxin Wu, Zhe Cong, Kejian Liu, Chuan Qin, Qiang Wei
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2014/387950
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection.
by: Haiying Li, et al.
Published: (2014-12-01)

Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV.
by: Nami Iwamoto, et al.
Published: (2021-01-01)

MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques.
by: Nathalie Dereuddre-Bosquet, et al.
Published: (2012-01-01)

Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21.
by: Suresh Pallikkuth, et al.
Published: (2013-01-01)

Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.
by: Vishakha Sharma, et al.
Published: (2021-12-01)

A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants.
by: Patrick Barnable, et al.
Published: (2014-01-01)

CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells.
by: Luca Micci, et al.
Published: (2014-10-01)

An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.
by: Jessica Kenney, et al.
Published: (2011-01-01)

Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques.
by: Daniel R Ram, et al.
Published: (2018-05-01)

Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques
by: Pingchao Li, et al.
Published: (2023-12-01)

Attenuated Disease in SIV-Infected Macaques Treated with a Monoclonal Antibody against FasL
by: Maria S. Salvato, et al.
Published: (2007-01-01)

Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.
by: Daniel Mendoza, et al.
Published: (2013-02-01)

SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.
by: Omotayo Farinre, et al.
Published: (2025-01-01)

Persistent innate immune dysfunction and ZIKV replication in the gastrointestinal tract during SIV infection in pigtail macaques
by: Jennifer Tisoncik-Go, et al.
Published: (2025-03-01)

Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques
by: Ziyu Wen, et al.
Published: (2025-04-01)

Rectal application of a highly osmolar personal lubricant in a macaque model induces acute cytotoxicity but does not increase risk of SHIV infection.
by: Sundaram A Vishwanathan, et al.
Published: (2015-01-01)

Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing.
by: For Yue Tso, et al.
Published: (2012-01-01)

SHIV remission in macaques with early treatment initiation and ultra long-lasting antiviral activity
by: Michele B. Daly, et al.
Published: (2024-12-01)

Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques
by: Jessica Coppola, et al.
Published: (2025-06-01)

Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.
by: Eugene V Barsov, et al.
Published: (2011-01-01)

Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir.
by: Taina T Immonen, et al.
Published: (2021-06-01)

Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS.
by: Mark Page, et al.
Published: (2014-01-01)

Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques.
by: Mayla Hsu, et al.
Published: (2014-01-01)

Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection.
by: Marjet Elemans, et al.
Published: (2011-03-01)

Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model.
by: Christopher Kline, et al.
Published: (2013-01-01)

Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
by: Brandon F Keele, et al.
Published: (2024-04-01)

Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.
by: Jörn E Schmitz, et al.
Published: (2009-12-01)

Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques.
by: Caroline Soulas, et al.
Published: (2015-01-01)

IL-17A-producing NKp44(−) group 3 innate lymphoid cells accumulate in Familial Adenomatous Polyposis duodenal tissue
by: Kim M. Kaiser, et al.
Published: (2025-04-01)

Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques.
by: Binhua Ling, et al.
Published: (2014-01-01)

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques.
by: Moritz Ries, et al.
Published: (2017-07-01)

Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review
by: Chuxian Mai, et al.
Published: (2025-01-01)

SIV vpx is essential for macrophage infection but not for development of AIDS.
by: Susan V Westmoreland, et al.
Published: (2014-01-01)

Pre-challenge gut microbial signature predicts RhCMV/SIV vaccine efficacy in rhesus macaques
by: Hayden N. Brochu, et al.
Published: (2024-11-01)

Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.
by: Sarah J Byrnes, et al.
Published: (2023-03-01)

Epigenetic modulation of the NLRP6 inflammasome sensor as a therapeutic modality to reduce necroptosis-driven gastrointestinal mucosal dysfunction in HIV/SIV infection
by: Lakmini S. Premadasa, et al.
Published: (2025-04-01)

CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection.
by: Olivia E Harwood, et al.
Published: (2023-09-01)

Natural killer cell cytokine response to M. bovis BCG Is associated with inhibited proliferation, increased apoptosis and ultimate depletion of NKp44(+)CD56(bright) cells.
by: Damien Portevin, et al.
Published: (2013-01-01)

Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen
by: Joseph Jelinski, et al.
Published: (2023-12-01)

HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys.
by: Brian Moldt, et al.
Published: (2022-04-01)